Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xeris Pharmaceuticals Inc (NQ: XERS ) 3.220 -0.010 (-0.31%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Xeris Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 Next > Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™ March 30, 2023 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma Appoints Ricki Fairley to Board of Directors March 29, 2023 From Xeris Biopharma Holdings Via Business Wire Xeris Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance March 08, 2023 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Pharmaceuticals's Earnings Outlook March 07, 2023 Via Benzinga Earnings Scheduled For March 8, 2023 March 08, 2023 Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. Via Benzinga Xeris Biopharma to Report Fourth Quarter and Full-Year 2022 Financial Results on March 8, 2023 February 23, 2023 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Participate in the SVB Securities Global Biopharma Conference 2023 February 02, 2023 From Xeris Biopharma, Inc. Via Business Wire Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev® January 30, 2023 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Present at 41st Annual J.P. Morgan Healthcare Conference January 05, 2023 From Xeris Biopharma Holdings, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Thursday January 05, 2023 On Thursday, 63 companies set new 52-week lows. Via Benzinga Xeris Biopharma Updates Its Outlook For 2022 January 05, 2023 From Xeris Biopharma Holdings, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Wednesday January 04, 2023 On Wednesday, 35 companies reached new 52-week lows. Via Benzinga Xeris Biopharma Announces Plans for a Phase II Dose-Finding Study for Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121) as Replacement Therapy for Hypothyroidism December 15, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect™ Formulation of Teprotumumab November 23, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma Reports Third Quarter 2022 Financial Results and Recent Events November 09, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire Earnings Scheduled For November 9, 2022 November 09, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million. Via Benzinga Xeris Biopharma to Report Third Quarter 2022 Financial Results on November 9, 2022 November 02, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma Announces Results of the Extended Evaluation of Recorlev® (Levoketoconazole) From the Phase 3 Sonics Study Published in the European Journal of Endocrinology November 01, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire 10 Best Medical Stocks Under $5 October 29, 2022 The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the... Via Talk Markets Xeris Biopharma Posts Encouraging Data From Reformulated Thyroid Hormone Deficiency Treatment In Healthy Participants October 20, 2022 Via Benzinga Xeris Biopharma Announces Positive Topline Phase 1 Clinical Data of Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121); Hosts Conference Call and Webcast October 20, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire 121 Stocks That Hit Their 52-Week Low October 14, 2022 New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. Via Benzinga Xeris Biopharma Reports Second Quarter Financial Results and Upcoming Events August 10, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire Earnings Scheduled For August 10, 2022 August 10, 2022 Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter. Via Benzinga Xeris Biopharma to Report Second Quarter 2022 Financial Results on August 10, 2022 August 03, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris’ Commercialization Partner for Ogluo®, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics August 01, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 16, 2022 It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news for Thursday morning. Via InvestorPlace 27 Stocks Moving in Thursday's Pre-Market Session June 16, 2022 Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) rose 92.9% to $3.28 in pre-market trading following’s Wednesday IPO. Via Benzinga Xeris Announces Full Results From the Logics Study of Recorlev® and Presentation of New Burden of Illness in Cushing’s Syndrome Data at AACE Annual Meeting May 12-14 May 12, 2022 From Xeris Biopharma Holdings, Inc. Via Business Wire 73 Biggest Movers From Yesterday May 17, 2022 Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
